Immunovant, Inc. - Common Stock, $0.0001 par value per share (IMVT)

Historical Holders from Q4 2019 to Q1 2025

Symbol
IMVT on Nasdaq
CUSIP
45258J102
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
170M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
80.1M
Holdings value
$1.98B
% of all portfolios
0.007%
Grand Portfolio weight change
+0%
Number of holders
188
Number of buys
94
Number of sells
-89
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immunovant, Inc. - Common Stock, $0.0001 par value per share (IMVT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Roivant Sciences Ltd. 56.9% 0% $1.65B 96.7M 0% Roivant Sciences Ltd. Apr 21, 2025
FMR LLC 10.1% $292M 17.1M FMR LLC Feb 28, 2025
Deep Track Capital, LP 5.59% $162M 9.5M Deep Track Capital, LP Mar 19, 2025

Institutional Holders of Immunovant, Inc. - Common Stock, $0.0001 par value per share (IMVT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 108K $1.85M -$121K $17.09 11
2024 Q4 80.1M $1.98B +$3.03M $24.77 188
2024 Q3 78.6M $2.24B +$115M $28.51 185
2024 Q2 74.7M $1.97B +$112M $26.40 198
2024 Q1 69.6M $2.25B -$5.73M $32.31 211
2023 Q4 68.4M $2.88B +$4.85M $42.13 226
2023 Q3 68.1M $2.62B +$461M $38.39 179
2023 Q2 55.5M $1.05B -$33.1M $18.97 145
2023 Q1 58.3M $904M +$20.9M $15.51 141
2022 Q4 56.5M $1B +$239M $17.75 131
2022 Q3 42.5M $237M +$14.2M $5.58 105
2022 Q2 39.4M $154M +$1.51M $3.90 86
2022 Q1 39.2M $216M +$6.84M $5.51 105
2021 Q4 37.7M $321M -$4.3M $8.52 117
2021 Q3 33.8M $294M -$49.3M $8.69 120
2021 Q2 38.5M $407M -$67.5M $10.57 115
2021 Q1 40.2M $645M -$273M $16.04 117
2020 Q4 40.3M $1.86B +$40M $46.19 145
2020 Q3 39.8M $1.4B +$384M $35.19 113
2020 Q2 28.6M $696M +$385M $24.35 87
2020 Q1 12.6M $194M +$15.2M $15.56 41
2019 Q4 11M $171M +$158M $15.87 23